Lacosamide Tecnigen (Lacosamide)

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels and binds to CRMP2, stabilising neuronal membranes. This reduces neuronal hyper‑excitability and limits the spread of epileptic discharges, helping to prevent seizures.

The specific dose and titration schedule are determined by the prescribing clinician based on the individual’s medical condition, response, and tolerability. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for lacosamide during pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks and discuss alternative options when appropriate. Breastfeeding decisions should also be made in consultation with a physician.

To request Lacosamide Tecnigen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lacosamide’s unique mechanism—enhancing slow sodium‑channel inactivation—differs from many traditional agents that target fast inactivation. Compared with drugs like carbamazepine or phenytoin, lacosamide often has a more favourable cognitive side‑effect profile, but individual response varies and choice depends on patient‑specific factors.

Store Lacosamide Tecnigen at room temperature, below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains sealed until use.

Lacosamide Tecnigen is taken orally. The tablets should be swallowed whole with water and may be taken with or without food, according to the prescriber’s guidance.

Serious adverse events include suicidal thoughts or behaviour, severe skin reactions such as Stevens‑Johnson syndrome, and cardiac arrhythmias, particularly PR‑interval prolongation. Patients should seek immediate medical attention if they experience any of these symptoms.

Lacosamide is contraindicated in patients with known hypersensitivity to lacosamide or any of its excipients. Caution is advised for individuals with significant cardiac conduction abnormalities, severe renal or hepatic impairment, and those taking interacting medications that cannot be adjusted.